Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB)

62 filings reported holding YMAB - Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2019.
Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 10,972,436 shares of 45,101,565 outstanding shares and own 24.33% of the company stock.
Largest 10 shareholders include Sofinnova Investments, Inc. (2,104,278 shares), FMR LLC (1,626,642 shares), BlackRock Inc. (1,153,831 shares), Cormorant Asset Management, LP (1,000,000 shares), PRICE T ROWE ASSOCIATES INC /MD/ (748,351 shares), ALLIANCEBERNSTEIN L.P. (744,155 shares), VANGUARD GROUP INC (489,582 shares), MILLENNIUM MANAGEMENT LLC (402,493 shares), Artal Group S.A. (400,000 shares), and STATE STREET CORP (322,057 shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.